Extracellular matrix and biomimetic engineering microenvironment for neuronal differentiationDeepak Jain, Sabrina Mattiassi, Eyleen L. Goh, Evelyn K.F. Yim573-585
Extracellular vesicles in the diagnosis and treatment of central nervous system diseasesAlisa A. Shaimardanova, Valeriya V. Solovyeva, Daria S. Chulpanova, Victoria James, Kristina V. Kitaeva, Albert A. Rizvanov586-596
Evidence and explanation for the involvement of the nucleus accumbens in pain processingHaley N. Harris, Yuan B. Peng597-605
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionBridget Martinez, Philip V. Peplow606-619
Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system:implications for neurorepair in the ischemic brainManuel Yepes620-624
Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participationHenrique Rocha Mendon?a, Raul Carpi-Santos, Karin da Costa Calaza, Ana Maria Blanco Martinez625-635
Relationship between MRI perfusion and clinical severity in multiple sclerosisMaria Marcella Lagan, Laura Pelizzari, Francesca Baglio646-652
Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseasesRubaiya Tabassum, Na Young Jeong, Junyang Jung653-662
Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumabStefan Gingele, Thomas Skripuletz, Roland Jacobs663-664
